Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Partial nephrectomy in renal cell carcinoma].

M A López-Costea1, C González-Satué, E Franco Miranda

  • 1Servicio de Urología, Ciutat Sanitaria i Universitaria de Bellvitge (CSUB), Barcelona.

Actas Urologicas Espanolas
|September 6, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Treatment with hydroxocobalamin for cyanide poisoning: a rare cause of pseudohematuria].

Actas urologicas espanolas·2010
Same author

[Our experience in high-flow priapism due to uni-or bilateral arterio-lacunar fistula].

Actas urologicas espanolas·2007
Same author

[Penile incarceration of thick metal].

Actas urologicas espanolas·2006
Same author

[Intracavernosal methoxamine self-injection for the treatment of low-flow recurrent priapism].

Actas urologicas espanolas·2006
Same author

[Renal pseudotumor secondary to acute pancreatitis. Report of one case].

Actas urologicas espanolas·2005
Same author

[Incomplete urethral duplication].

Actas urologicas espanolas·2005

Nephron Sparing Surgery (NSS) is a safe and effective treatment for renal cell carcinoma (RCC), particularly for small tumors. This study shows high survival rates and low morbidity with NSS, making it a valuable option for kidney cancer patients.

Area of Science:

  • Urology
  • Oncology
  • Surgical Oncology

Context:

  • Renal Cell Carcinoma (RCC) is a significant malignancy, with increasing incidental diagnoses of small renal tumors.
  • The management of small renal masses often involves a balance between oncological control and preservation of renal function.
  • Nephron Sparing Surgery (NSS) has emerged as a key surgical approach for selected renal tumors.

Purpose:

  • To evaluate the outcomes of Nephron Sparing Surgery (NSS) for renal masses over a decade.
  • To compare outcomes between elective and obligatory NSS.
  • To assess the morbidity, mortality, and survival rates associated with NSS.

Summary:

  • A retrospective analysis included 65 NSS procedures for renal tumors between 1990 and 2000.
  • The study differentiated between elective (tumors <4cm, normal contralateral kidney) and obligatory NSS.

Related Experiment Videos

  • Results demonstrated a cancer-specific survival of 98.4% and global survival of 90.3% at 36 months, with a morbidity rate of 10.8% and mortality of 1.5%.

    • Impact:

    • NSS is a viable and effective treatment for renal cell carcinoma, especially for tumors under 4 cm.
    • The technique is also beneficial for patients with a solitary kidney, preserving renal function.
    • These findings support the continued application of NSS in the management of renal tumors.